Charybdotoxin (TFA)

• Description:

  Charybdotoxin TFA, a 37-amino acid peptide, is a K+ channel blocker[1].

• UNSPSC:

  12352209

• Target:

  Potassium Channel

• Type:

  Peptides

• Related Pathways:

  Membrane Transporter/Ion Channel

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/charybdotoxin-tfa.html

• Purity:

  98.84

• Solubility:

  H2O : ≥ 100 mg/mL

• Smiles:

  [{Glp}-FTNVSCTTSKECWSVCQRLHNTSRGKCMNKKCRCYS(Disulfidebridge:Cys7-Cys28;Cys13-Cys33;Cys17-Cys35)(TFAsalt)]

• Molecular Formula:

  C176H277N57O55S7.xC2HF3O2

• Molecular Weight:

  4295.89 (free acid)

• References & Citations:

  [1]M L Garcia , et al. Charybdotoxin and its effects on potassium channels. Am J Physiol. 1995 Jul;269 (1 Pt 1) :C1-10.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported